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Objective - To assess the results of surgical myocar-
dial revascularization in renal transplant patients.
Methods - From 1991 to 2000, 11 renal transplant
patients, whose ages ranged from 36 to 59 (47.5±8) years,
8 males and 3 females, underwent myocardial revasculari-
zation. The time interval between renal transplantation
and myocardial revascularization ranged from 25 to 120
(mean of 63.8±32.7) months.
Results - The in-hospital mortality rate was 9%. One
patient died on the 4th postoperative day from septicemia
and respiratory failure. The mean graft/patient ratio was
2.7±0.8. Only 1 patient required slow hemodialysis during
24 hours in the postoperative period, and no patient had a
definitive renal lesion or lost the transplanted kidney. The
actuarial survival curves after 1, 2, and 3 years were,
respectively, 90.9%, 56.8%, and 56.8%.
Conclusion - Renal transplant patients may undergo
myocardial revascularization with no lesion in or loss of
the transplanted kidney.
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Cardiovascular disease is the major cause of mortality
in patients with advanced chronic renal failure and in those
undergoing renal transplantation 1-4. Several factors, such
as hypertension, alterations in lipid metabolism, diabetes,
and immunosuppressive therapy, accelerate cardiovascular
disease in renal transplant patients and in those under-
going dialysis 1-4. It is worth noting that myocardial infarc-
tion as a cause of death in these patients exceeds 20% 4,5.
In addition, Manske et al 6 reported that in patients
with an indication for renal transplantation, in whom myo-
cardial ischemia was identified, myocardial revasculari-
zation reduced the risk of renal transplantation and in-
creased immediate survival.
The first myocardial revascularization surgeries in renal
transplant patients were performed in the beginning of the
1970s 7-9. Since then, not only have transplantation and im-
munosuppression techniques greatly developed, but dialytic
methods have also. This has resulted in an expressive and
progressive increase in these patients’ survival, making this
population subject to coronary atherosclerotic disease part of
the daily routine of cardiovascular surgery services.
This study aimed at assessing the results of myocar-
dial revascularization surgery in renal transplant patients.
Methods
We carried out a retrospective study in patients with
advanced chronic renal disease, who had undergone renal
transplantation and, in the postoperative clinical follow-up,
developed coronary heart disease and underwent myocar-
dial revascularization. Patients undergoing procedures asso-
ciated with revascularization were excluded from the study.
From 1991 to 2000, 11 renal transplant patients under-
went myocardial revascularization. Their ages ranged from
36 to 59 (mean of 47.5±8) years; 8 were males and 3 were fe-
males. The interval between renal transplantation and myo-
cardial revascularization ranged from 25 to 120 (mean of
63.8±32.7) months.
The indication for myocardial revascularization sur-
gery in these cases did not differ from the usual indications
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in patients with no renal failure. For surgical treatment, the
following patients were considered: patients with three-
vessel disease, those with lesions in the trunk of the left
coronary artery, and those with two-vessel disease and
lesions close to the anterior interventricular artery.
Associated diseases were observed in 8 patients, hy-
pertension being present in all of them, dyslipidemia in 4,
peripheral vascular disease in 2, type II diabetes mellitus in
3, obesity in 1, and chronic obstructive pulmonary disease
in another. Four patients reported tobacco use.
Three patients were in functional class IV for angina, 5
were in functional class III, and 3 were in functional class II.
Four patients had experienced previous myocardial infarc-
tion, confirmed on electrocardiography (presence of Q wave),
7 patients had symptoms of cardiac failure associated with
symptoms of coronary heart disease, 2 (22%) of whom were
in NYHA functional class III and 5 in functional class II.
Coronary angiography showed three-vessel coronary
artery disease in 8 (66.6%) patients and two-vessel disease
in 3 (33.3%).
Left ventricular function was assessed in the preope-
rative period with Doppler echocardiography in 6 patients,
and in 3 patients the mean ejection fraction was estimated as
0.73±0.12 (ranging from 0.61 to 0.85). No patient had severe
ventricular dysfunction in the preoperative period.
All data are shown as mean ± standard deviation. Long-
term survival was estimated with the Kaplan-Meier method.
Results
In-hospital mortality was 9%, and 1 patient died on the
4th postoperative day from septicemia and respiratory failure.
The mean graft/patient ratio was 2.7±0.8. The left inter-
nal thoracic artery was used to revascularize the anterior
interventricular artery in 9 (77.7%) patients and the dia-
gonal artery in 2 (22.2%). The great saphenous vein was
used to revascularize the other arteries. In 8 patients, the
operation was performed with extracorporeal circulation
and cardioplegic arrest, and in 3 patients without extracor-
poreal circulation.
The mean creatinine value in the preoperative period
was 2.0±0.8 mg/dL. Only 1 patient required dialysis in the
postoperative period of revascularization, slow hemodialy-
sis for 24 hours. This patient had a significant reduction in
urinary output, with hyperpotassemia and signs of pulmo-
nary congestion. We chose to maintain slow hemodialysis
in the patient until normalization of renal function and meta-
bolic correction, which happened in the subsequent 24
hours. No patient experienced a definite worsening of renal
function or loss of the transplanted kidney, or even perio-
perative myocardial infarction. One patient had atrial fibril-
lation with a high ventricular response, which was chemi-
cally reverted, and another patient experienced periods of
mental confusion.
Three patients had pneumonia, 1 evolved to septice-
mia and respiratory failure, which was the cause of the only
death in this population. Another patient with pulmonary
infection required reintubation and had a good evolution.
No hemorrhagic complications or reoperations due to
bleeding occurred.
Hospital stay ranged from 11 to 42 days (mean of
19.2±10 days), and intensive care unit stay ranged from 2 to
15 days (mean of 4.2±4.4 days).
Follow-up ranged from 1 to 90 months (mean of
32.8±34.4 months). Eight patients were in functional class I
in the postoperative period and the remaining were in
functional class II.
Two patients were not followed up in our service,
being referred to their original places. One patient died due
to enterorrhagia secondary to colonic diverticular disease
23 months after revascularization.
The actuarial survival curves (Kaplan-Meier method)
after 1, 2, and 3 years were, respectively, 90.9%, 56.8%, and
56.8% (fig. 1).
Discussion
In this study, myocardial revascularization in renal
transplant patients was performed with no subsequent
definitive lesions in or loss of the transplanted kidney, pul-
monary infection being the major complication observed in
the postoperative period.
Several risk factors during and following the surgery
have been reported in the literature, factors that may lead to
transplanted kidney loss or lesions, among which we can
cite hemodynamic alterations occurring due to the use of
extracorporeal circulation 8, hyperpotassemia, drug accu-
mulation, cardiac arrhythmias 10,11, septicemia, and coagu-
lation disorders 11,12.
In this study, 3 (27.2%) patients had pulmonary infec-
tion, 1 of whom evolved to septicemia with respiratory fai-
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Fig. 1 – Survival curve of the renal transplant patients undergoing myocardial
revascularization surgery.
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lure, which was the cause of the only death in this case se-
ries. Although the risk of infection should always be kept in
mind, reports in the literature are mixed. Bolman et al 13
reported 3 cases of infection in 14 patients operated on; on
the other hand, Christiansen et al 14, Beauchamp et al 9 and
Chawla et al 15, in short case series, did not report this com-
plication. It is important to emphasize that the risk of
infections in these patients was attributed to the prolonged
use of corticoids and immunosuppressants 8,10.
The first successful myocardial revascularization in a
renal transplant patient was reported in 1975 by Nakhjavan
et al 8 as a case report. Since then, reports on the experience
of surgical teams with this type of patient have been scarce,
most of them in the form of case reports or small case series
(tab. I 7-9,13,14,16-25).
In 1997, Dresler et al 26 carried out a study, one of the
largest case series in the literature, with 45 renal transplant
patients undergoing cardiac surgery, 31 being myocardial
revascularization. They reported an in-hospital mortality rate of
8.8%, septicemia being the major cause of death. No patient
lost the transplanted kidney in the perioperative period.
The in-hospital mortality rate in our study was 9%, si-
milar to that reported in the literature.
Another important issue regards the use of extracor-
poreal circulation that represents in this type of patient the
major risk for renal ischemia. This risk increases when the
duration of extracorporeal circulation exceeds 60 minutes 14.
In our study, no patient had a definitive lesion in the
transplanted kidney, but 1 had a reduction in renal func-
tion, requiring slow hemodialysis for 24 hours in the
postoperative period. This may have resulted from a re-
duction in renal perfusion during surgery due to extra-
corporeal circulation.
Currently, the appearance of minimally invasive sur-
gery, whose major characteristic is not using extracorporeal
circulation, is an excellent alternative surgical technique in
renal transplant patients. Most of our patients had three-
vessel disease and were operated on with extracorporeal
circulation with no subsequent lesions in the transplanted
kidney, because, at that time, no technical alternatives exis-
Table I - List of authors with number of patients and in-hospital
mortality
Authors Year N° patients Mortality (%)
Nakhjavan et al 8 1975 1 0
Lamberti et al 7 1975 1 0
Beauchamp et al 9 1976 3 0
Bolman et al 13 1984 10 10
Golan et al 16 1987 1 0
Defraigne et al 17 1990 1 0
Meyer et al 18 1991 8 0
Yamamura et al 19 1993 1 0
Ando et al 20 1993 2 0
Tezcaner et al 21 1996 1 0
Christiansen et al 14 1999 4 0
Mitruka et al 22 1997 18 5,5
Dagenais et al 1998 20 10
Noda et al 24 1999 2 0
Taketani et al 25 2000 1 0
ted for approaching the left marginal artery without extra-
corporeal circulation 27. Because this study had a very small
sample, the possible differences between operating on renal
transplant patients with or without extracorporeal circulation
could not be identified.
Although our data do not allow an effective conclu-
sion about the effects of extracorporeal circulation in the
transplanted kidney in the in-hospital and late periods, the
current literature has stressed that surgery without extra-
corporeal circulation has its major benefit in patients with
clinical morbidity in the preoperative period 28-30.
The in-hospital mortality rate in renal transplant pati-
ents has been reported as approximately 10% in the largest
case series. We observed that these surgeries have also
been performed with extracorporeal circulation, and we
believe that this mortality rate may be reduced in the coming
years, when most of these procedures will be performed wi-
thout extracorporeal circulation, and, therefore, with 1 less
factor of aggression to the transplanted kidney.
In conclusion, myocardial revascularization in renal
transplant patients may be performed with no definitive re-
nal lesion or loss of the transplanted kidney.
References
1. Burton BT, Kreuger KK, Bryan FA. National registry of long term dialysis pa-
tients. JAMA 1971; 218: 718-21.
2. Francis GS, Sharma B, Collins AJ, Helseth HK, Comty CM. Coronary artery sur-
gery in patients with end-stage renal disease. Ann Intern Med 1980; 92: 499.
3. Lindner A, Charra B, Sherrard J, Scriber B. Accelerated atherosclerosis in prolon-
ged maintenance dialysis. N Engl J Med 1974; 290: 697.
4. Opsahl JA, Husebye DG, Helseth HK, Collins AJ. Coronary artery bypass surge-
ry in patients on maintenance dialysis: long term survival. Am J Kidney Dis
1988; 12: 271.
5. Frye EB, Vaziri ND, Martin DC, Farooqui S. Cardiovascular pathology in renal
transplant recipients. J Nat Med Ass 1986; 78: 1187.
6. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularization
in insulin-dependent diabetic patients  with chronic renal failure. Lancet 1992;
340: 998.
7. Lamberti JJ, Cohn LH, Collins JJ. Cardiac surgery in patients undergoing renal
dialysis or transplantation. Ann Thorac Surg 1975; 19: 135-41.
8. Nakhjavan FK, kahn A, Rosenbaun J, Ablaza S, Goldberg H. Aortocoronary
vein graft surgery in a cadaver kidney transplant recipient. Arch Intern Med
1975; 135: 1511-13.
9. Beauchamp GD, Sharma JN, Crouch T, et al. Coronary bypass surgery after renal
transplantation. Am J Cardiol 1976; 37: 1107-10.
10. Kuehnel E, Lundn H, Bennet W, Porter G. Aortocoronary bypass surgery in pa-
tients with end-stage renal desease. Trans Am Soc Intern Organs 1976; 22: 14-20.
11. Lansing AM, Loeb DE, Berman LB. Cardioascular surgery in end-stage renal fai-
lure. JAMA 1968; 204: 134-8.
12. Crawford FA Jr, Selby JH Jr, Bower JD, Lehan PH. Coronary revascularization in
patients maintained on chronic hemodialysis. Circulation 1977; 56: 684-7.
13. Bolman RM, Anderson RW, Molina JE, et al. Cardiac operation in patients with
functioning renal allografts. J Thorac Cardiovas Surg 1984; 88: 537-43.
Arq Bras Cardiol
2002; 79: 480-3.
Delgado et al
Myocardial revascularization in renal transplant patients
4 8 3
14. Christiansen S, Splittgerber FH, Marggraaf G, et al. Results of cardiac operations
in five kidney transplant atiens. Thorac Cardiovasc Surgeon 1999; 45: 75-77.
15. Chawla R, Gailiunas P, Lasaurus JM, et al. Cardiopulmonary bypass surgery in
chronic hemodialysis and transplant patients. Trans Am Soc Intern Organs 1977;
23: 694-7.
16. Golan M, Goor DA, Jacob ET. Coronary artery bypass surgery in cadaver kidney
transplant recipient. Int Surg 1987; 72: 565-57.
17. Defraine JO, Meurisse M, Limet R. Valvular and coronary surgery in renal trans-
plant patients. J Cardiovasc Surg 1990; 31: 581-3.
18. Meyer M, Wyns W, Dion R, Khoury G, Pirson Y, van Ypersele de Strihou C.
Myocardial revascularization in patients on renal replacement therapy. Clinical
Nephrology 1991; 3: 147-51.
19. Yamamura M, Miyamoto T, Murata H, Kitai K, Ueda T, Wada T. A case of myocardial
revascularization in a patient renal transplant. Nippon Kyobu Geka Zasshi
1993; 41: 503-08.
20. Ando MH, Koyanagi M, Endo M, Nishida H, Hachida M, Teraoka S. A report of
two cases of coronary bypass surgery after renal transplantation. Nippon Kyobu
Geka Gakkai Zasshi 1993; 41: 2126-30.
21. Tezcaner T, Yorgancioglu C, Molbidi O, Catav Z, Erbay B, Zorlutuna IY. Corona-
ry bypass surgery in a renal transplant patient. Intern Urology Nephrology
1996; 28: 583-7.
22. Mitruka SN, Griffith BP, Kormos RL, et al. Cardiac operations in solid-organ
transplant recipients. Ann Thorac Surg 1997; 64: 1270-8.
23. Dagenais F, Voisine P, Normandin L, Martin M, Poirier NL. La chirurgie car-
diaque chez le patient greffé rénal: à propos de 24 cas. Annal Chirurgie 1998;
52: 834-9.
24. Noda H, Fijimura Y, Gohra H, Hamano K, Katoh T, Esato K. Coronary bypass sur-
gery after renal transplanttation. Jpn J Thoracic Cardiovascular Surg 1999; 47:
135-40.
25. Taketani S, Fukushima N, Ohtake S, Sawa Y, Nishimura M, Matusda H. Coronary
artery bypass graft in a renal transplant recipient. Jpn J Thoracic Cardiovasc Surg
2000; 48: 542-4.
26. Dresler C, Uthoff K, Wahlers T, et al. Open heart operations after renal transplan-
tation. Ann Thorac Surg 1998; 65: 596.
27. Lima RC. Padronização da técnica de revascularização do miocárdio da artéria cir-
cunflexa e seus ramos sem circulação extracorpórea. (Tese de Doutorado). Univer-
sidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, SP.
28. Yokoyama T, Baumgartner FJ, Gheissari A, Capouya ER, Panagiotides GP, De-
clusion RJ. Off-pump versus on-pump coronary bypass in high-risk subgroups.
Ann Thorac Surg 2000; 70: 1546-50.
29. Güller M, Kirali K, Toker ME, et al. Different CABG methods in patients with
chronic obstrutive pulmonary disease. Ann Thorac Surg 2001; 71: 152-57.
30. Ricci M, Karamanoukian HL, Abraham R, et al. Stroke in octagenarians under-
going coronary artery surgery with and without cardiopulmonary bypass. Ann
Thorac Surg 2000; 69: 1471-5.
